Latest for Chronic Granulomatous Disease
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Who can joinWho can join changed for Evaluation of Patients With Immune Function AbnormalitiesClinicalTrials.gov
- Who can joinWho can join changed for Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous… (Phase 1/2)ClinicalTrials.gov
- Who can joinWho can join changed for pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With… (Phase 1/2)ClinicalTrials.gov
More about Chronic Granulomatous Disease
Affected neutrophils and macrophages cannot produce the respiratory burst necessary to kill catalase-positive organisms including Staphylococcus aureus, Serratia, Nocardia, Aspergillus, and Burkholderia cepacia.
Keep reading about Chronic Granulomatous Disease
Patients typically develop recurrent severe bacterial and fungal infections starting in infancy or early childhood, including suppurative lymphadenitis, hepatic and splenic abscesses, chronic pneumonia with granuloma formation, osteomyelitis, and skin infections. Excessive granuloma formation at infection sites and in draining lymph nodes can cause significant obstruction of the GI tract, genitourinary system, and respiratory tract. Prognosis has dramatically improved with prophylactic antimicrobials and interferon-gamma therapy; median survival now exceeds 40 years.
What are the symptoms of Chronic Granulomatous Disease?
These are common symptoms of Chronic Granulomatous Disease, and how strong they are varies from person to person.
- Severe, recurrent infections (bacteria and fungi)
- Granuloma formation affecting multiple organs
- Lymphadenitis and hepatosplenomegaly
- Lung infections and granulomas
- GI complications including obstruction
- Osteomyelitis and skin infections
Who gets Chronic Granulomatous Disease?
X-linked CGD, which mostly affects boys, accounts for about 70% of cases, according to MedlinePlus Genetics, and usually shows up in infancy or early childhood. Autosomal recessive forms affect both males and females equally and show equal distribution across all ethnic populations.
Geographic variation is minimal; however, certain populations show increased carrier frequencies due to founder effects. Manifestations typically begin in infancy (first months to years of life), though some patients with specific mutations demonstrate delayed presentation. Approximately 5-10% of CGD cases are detected in adulthood.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Chronic Granulomatous Disease?
There is currently 1 FDA-approved medication for Chronic Granulomatous Disease.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Chronic Granulomatous Disease treatment
Charity funds and drugmaker programs for Chronic Granulomatous Disease, checked at the source.
- From a charity · Good DaysChronic Granulomatous Disease fundOpen
Pays for: Copays for FDA-approved medications (plus travel for some funds), up to $10,000 per year. Requires health insurance (any kind).
The foundation says: “Program Status: open.” - From a charity · The Assistance FundChronic Granulomatous Disease (CGD) fundOpen
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
Every program and fund for Chronic Granulomatous Disease, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Chronic Granulomatous Disease
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Chronic Granulomatous Disease resources
Reputable organizations and medical references for learning more about Chronic Granulomatous Disease, including disease registries, foundation resources, and clinical guidelines.